A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and products for ...

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation is proud to announce the implantation of a spinal cord epidural stimulator in an individual with paralysis, marking a ...

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...

Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...

Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.

Neurosurgeon Jocelyne Bloch, MD, and neuroscientist Grégoire Courtine, PhD, co-direct their lab, NeuroRestore, and are working to use artificial intelligence-driven implants to help spinal cord injury ...

In a groundbreaking pilot study, researchers have found evidence that spinal cord stimulation could potentially benefit ...

A former state representative from Auburn who is currently serving as Georgia Speaker of the House Jon Burns' chief of staff ...

It's a piano riff that fires off an anthem we all know by heart. "I Will Survive" is a disco masterpiece by two-time Grammy ...